Cargando…

Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand

BACKGROUND: New Zealand (NZ) is considering transitioning from 3-yearly cervical cytology screening in women 20–69 years (current practice) to primary HPV screening. We evaluated HPV-based screening in both HPV-unvaccinated women and cohorts offered HPV vaccination in New Zealand (vaccination covera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lew, Jie-Bin, Simms, Kate, Smith, Megan, Lewis, Hazel, Neal, Harold, Canfell, Karen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871332/ https://www.ncbi.nlm.nih.gov/pubmed/27187495 http://dx.doi.org/10.1371/journal.pone.0151619

Ejemplares similares

Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia
por: Hall, Michaela T., et al.
Publicado: (2018)

Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia
por: Simms, Kate T., et al.
Publicado: (2017)

Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand
por: Kang, Yoon-Jung, et al.
Publicado: (2015)

Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand
por: Simonella, Leonardo M, et al.
Publicado: (2013)

Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use
por: Smith, Megan A., et al.
Publicado: (2016)

Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia
por: Smith, Megan A., et al.
Publicado: (2017)

The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling study
por: Hall, Michaela T., et al.
Publicado: (2020)

Self‐collection for HPV screening: a game changer in the elimination of cervical cancer
por: Canfell, Karen, et al.
Publicado: (2021)

National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study
por: Smith, Megan A, et al.
Publicado: (2022)

A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia
por: Nickson, Carolyn, et al.
Publicado: (2023)

Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study
por: Legood, Rosa, et al.
Publicado: (2012)

Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study
por: Shi, Ju-Fang, et al.
Publicado: (2011)

Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years
por: Creighton, Prudence, et al.
Publicado: (2010)

Incremental Benefits of Male HPV Vaccination: Accounting for Inequality in Population Uptake
por: Smith, Megan A., et al.
Publicado: (2014)

Expenditure and resource utilisation for cervical screening in Australia
por: Lew, Jie-Bin, et al.
Publicado: (2012)

HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control
por: Canfell, Karen, et al.
Publicado: (2019)

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
por: Brisson, Marc, et al.
Publicado: (2020)

Population-based utility scores for HPV infection and cervical squamous cell carcinoma among Australian Indigenous women
por: Ju, Xiangqun, et al.
Publicado: (2021)

Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening
por: Velentzis, Louiza S., et al.
Publicado: (2023)

Development and application of a framework to estimate health care costs in China: The cervical cancer example
por: Liu, Yi-Jun, et al.
Publicado: (2019)

The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost‐effectiveness of human papillomavirus screening with self‐collection and digital registry support
por: Keane, Adam, et al.
Publicado: (2021)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea
por: Nguyen, Diep Thi Ngoc, et al.
Publicado: (2022)

Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia
por: Canfell, Karen, et al.
Publicado: (2018)

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019)

Working towards a comprehensive understanding of HPV and cervical cancer among Indigenous women: a qualitative systematic review
por: Sethi, Sneha, et al.
Publicado: (2021)

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence
por: Arbyn, Marc, et al.
Publicado: (2020)

Prevention of Cervical Cancer through HPV Vaccination and Screening in Maldives
por: Mullapally, Sujith Kumar, et al.
Publicado: (2023)

Effective HPV vaccination coverage in Australia by number of doses and two-dose spacing: What if one or two doses are sufficient?
por: Smith, Megan A., et al.
Publicado: (2021)

Economic Evaluation of Screening Strategies Combined with HPV Vaccination of Preadolescent Girls for the Prevention of Cervical Cancer in Vientiane, Lao PDR
por: Chanthavilay, Phetsavanh, et al.
Publicado: (2016)

Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India
por: Diaz, M, et al.
Publicado: (2008)

Progress in eliminating HPV-associated disease
por: Stern, Peter L., et al.
Publicado: (2019)

Impact of organised cervical screening on cervical cancer incidence and mortality in migrant women in Australia
por: Aminisani, Nayyereh, et al.
Publicado: (2012)

The Possible Effects on Socio-Economic Inequalities of Introducing HPV Testing as Primary Test in Cervical Cancer Screening Programs
por: Giorgi Rossi, Paolo, et al.
Publicado: (2014)

A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccination
por: Velentzis, Louiza S, et al.
Publicado: (2023)

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial
por: Canfell, Karen, et al.
Publicado: (2017)

Can HPV Selfy be considered as a clinically validated HPV test for use in cervical cancer screening?
por: Arbyn, Marc, et al.
Publicado: (2022)

A survey of population-based utility scores for cervical cancer prevention
por: Simonella, Leonardo, et al.
Publicado: (2014)

HPV and cervical cancer: screening or vaccination?
por: Bosch, F X, et al.
Publicado: (2008)

The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis
por: Felix, Juan C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kf7vs1vdfakkl7u4g10qs9jp07